4D PHARMA
4D is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx, that rationally identifies novel bacteria that have a precise and evolved therapeutic effect. All of 4D's live biotherapeutic products are orally delivered single strains of bacteria that are naturally found in the healthy human gut. 4D currently has a pipeline of 15 therapeutic programmes covering autoimmune diseases, CNS disorders and cancer; with two programmes in patient trials, and the expectation to initiate another three programmes over the coming twelve months.
4D PHARMA
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Aberdeen, Aberdeen City, United Kingdom
Country:
United Kingdom
Website Url:
http://www.4dpharmaplc.com
Total Employee:
101+
Status:
Active
Contact:
+44 1224 900 460
Total Funding:
53.91 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Font Awesome Nginx
Similar Organizations
3billion
3billion is a world leader in the field of genetic diagnostics for rare disease.
ArriVent Biopharma
ArriVent develops pharmaceutical products to cure presently untreatable cancer.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Cosmo Pharmaceuticals
Cosmo is a speciality pharmaceutical company that aims to become a global leader in the market of optimised therapies.
ETHRIS
ETHRIS is a technical innovator in the emerging field of mRNA therapeutics and LNP delivery.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
IOmx Therapeutics
iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics.
Juventas
Juventas is a provider and developer of innovative immune cell therapeutic drugs.
Klaria Pharma Holding
Klaria's business concept is to develop and commercialize innovative products
Mithra Pharmaceuticals SA
Mithra Pharmaceuticals SA specializes in the development of women's health care products.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-04-08 | 4D Pharma León, S.L.U. | 4D Pharma León, S.L.U. acquired by 4D Pharma | 6 M EUR |
| 2016-02-10 | Tucana Health | Tucana Health acquired by 4D Pharma | N/A |
| 2014-07-18 | The Microbiota Company Ltd | The Microbiota Company Ltd acquired by 4D Pharma | N/A |
| 2014-06-04 | 4D pharma Research Ltd | 4D pharma Research Ltd acquired by 4D Pharma | N/A |
Investors List
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - 4D Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-03 | 4D Pharma Names John Doyle as Financial Chief |
| 2021-07-26 | 4D pharma Announces Passing of Chief Financial Officer John Beck |
Official Site Inspections
http://www.4dpharmaplc.com Semrush global rank: 1.55 M Semrush visits lastest month: 16.88 K
Unable to get host informations!!!
More informations about "4D Pharma"
4D Pharma - Crunchbase Company Profile & Funding
4D is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a …See details»
4D Pharma - Overview, News & Similar companies | ZoomInfo.com
Jan 3, 2022 View 4D Pharma (www.4dpharmaplc.com) location in West Yorkshire, United Kingdom , revenue, industry and description. ... 4D Pharma has announced that John Doyle …See details»
4D pharma plc - AnnualReports.com
Contents Highlights 1 Directors, Secretary and Advisors 3 Strategic report: Introduction 4 Strategic report: Business strategy 5 Strategic report: Chairperson and CEO’s statement 7 …See details»
4D Pharma PLC - AnnualReports.com
4D Pharma PLC is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the …See details»
4D pharma Announces Completion of Merger With …
Mar 22, 2021 For more information, refer to https://www.4dpharmaplc.com. Forward-Looking Statements. This announcement contains "forward-looking statements." All statements other than statements of historical ...See details»
4D pharma Company Profile 2024: Overview
Information on executives, investments, and subsidiaries for 4D pharma. Use the PitchBook Platform to explore the full profile.See details»
4d pharma plc - Company Profile and News - Bloomberg Markets
Company profile page for 4d pharma plc including stock price, company news, executives, board members, and contact informationSee details»
Company 4D pharma plc Deutsche Boerse AG - MarketScreener.com
Jan 19, 2007 Part of BacThera AG, 4D Pharma León SLU is a pharmaceutical company based in León, ES. 4D Pharma León SLU was acquired by BacThera AG from 4D Pharma Plc on …See details»
4D pharma plc Files SEC Forms in Process to Gain NASDAQ Listing ...
Oct 22, 2020 4D pharma Duncan Peyton, Chief Executive Officer +44 (0)113 895 0130 Investor Relations [email protected]. N+1 Singer - Nominated Adviser and Joint Broker +44 (0) ...See details»
4D pharma - Craft
Feb 14, 2023 See insights on 4D pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
4D pharma Reports Full Year 2021 Financial Results, Operational ...
Mar 31, 2022 4D pharma Investor Relations [email protected] Singer Capital Markets – Nominated Adviser and Joint Broker Philip Davies / James Fischer (Corporate Finance) +44 …See details»
4D pharma plc ("4D pharma") Receives Notice of Delisting From
Jun 28, 2022 4 D pharma plc, a pharmaceutical company leading the development of Live Biotherapeutic products, a novel class of drug derived from the microbiome, today announces …See details»
4D pharma plc (“4D pharma”) Receives Notice of Delisting From …
Jun 28, 2022 Contacts. 4D pharma Investor Relations [email protected] Singer Capital Markets - Nominated Adviser and Joint Broker Philip Davies / James Fischer (Corporate …See details»
4D pharma Announces Completion of Merger With Longevity
Mar 19, 2021 4D pharma Investor Relations: [email protected]. Stern Investor Relations, Inc. Julie Seidel +1-212-362-1200 [email protected]. Source: 4D pharma plc. In This …See details»
4D pharma plc announces merger with Longevity, a special …
Oct 28, 2020 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome - …See details»
4D pharma plc announces merger with Longevity, a special …
Oct 22, 2020 Merger agreement worth up to USD 37.6 millionUS listing will support and accelerate ongoing development of 4D pharma’s Live Biotherapeutics Leeds, UK, October 22 …See details»
4D pharma plc (“4D pharma”) Receives Notice of Delisting
Jun 28, 2022 LEEDS, England--(BUSINESS WIRE)-- 4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products …See details»
4D Pharma expanding clinical data in multiple indications
Jun 28, 2021 Preclinical-stage programs include candidates for CNS diseases such as Parkinson's disease and other neurodegenerative conditions; the company has been doing a …See details»
4D pharma appoints John Doyle as Chief Financial Officer
Jan 3, 2022 4D pharma Investor Relations: [email protected] Singer Capital Markets - Nominated Adviser and Joint Broker +44 (0)20 7496 3000 Philip Davies / James Fischer …See details»
4D Pharma Announces Private Placement - Business Wire
Mar 17, 2021 4D pharma plc Investor Relations: [email protected]. N+1 Singer - Nominated Adviser and Joint Broker +44 (0)20 7496 3000 Philip Davies / Iqra Amin / James Fischer …See details»